Neurotech inks European development deal for cannabinoid therapies
Special Report: Neurotech International has inked a deal with a European leader in development and scale up of cannabis-based ...
Rare opportunities – ASX health stocks tackling unmet medical needs
Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...
Northern Territory News17d
Phase III Trials: It’s crunch time for these ASX health stocks
The company's first drug candidate trofinetide – marketed as DAYBUE – is approved by the FDA and Health Canada for the treatment of Rett syndrome. Neuren has granted an exclusive worldwide licence to ...
Johns Hopkins Medicine19d
Zollinger-Ellison Syndrome
What is Zollinger-Ellison syndrome? Zollinger-Ellison syndrome (ZES) is a rare digestive disorder. If you have ZES, you likely have 1 or more tumors in the first part of the small intestine, the ...
Yahoo26d
Trump inauguration photos: From his arrival at the White House to his swearing-in at the Capitol Rotunda, see images from the historic day
Donald and Melania Trump arrive at the White House ahead of the inauguration ceremony on Monday in Washington, D.C. (Andrew Harnik/Getty Images) Donald Trump was sworn in as the 47th president of ...
Sky26d
Donald Trump's inauguration in pictures
Donald Trump is now the 47th president of the United States, as well as the 45th president, a businessman - and a man who knows how to put on a show. Former presidents, Trump family members, tech ...
El País in English26d
US presidential inaugurations: A timeline in pictures
EL PAÍS looks back at the swearing-in ceremony, which is held every four years at the Capitol in Washington Jan 20, 2025 - 12:56CET ...
stockhead29d
Scott Power: Telix achieves sustained growth; Pro Medicus wins another contract
Pro Medicus said Visage 7 would also provide enterprise distribution of images integrated to UK’s electronic ... for trofinetide for the treatment of Rett syndrome in adults and paediatric patients ...